Point-Of-Care Diagnostics 2.0: Beyond the Clinic

Point-of-care diagnostics (POCDs) have been essential tools in the rapid detection of biomarkers and analytes, which facilitates better disease diagnosis, monitoring, and management. However, with some exceptions like the pregnancy test kit and glucose test strips, first-generation POCDs have tradit...

This research is archived and therefore no longer available. For further assistance please contact your Customer Success Manager or email ClientEngagementTeam@luxresearchinc.com. Thank you!

Related Research

Seeking New Business Opportunities by Identifying Gaps in the Patient Journey

State of the Market Report | July 21, 2021

Healthcare systems in many countries have become more complex and confusing as a result of increasing expansion and specialization over the past decades. Patients are required to identify a suitable entry point to the healthcare system, to orientate themselves within a multitude of organizations, to... Not part of subscription

Unlocking new business opportunities earlier in the patient journey by integrating genomics technologies with existing healthcare products and services

Analyst Insight | August 28, 2021

Historically, genomic sequencing has been widely used in research settings for population‑scale data‑driven insights. With the increase in the availability of genomic data, genomics can also now be leveraged to derive actionable health insights at the individual level, unlocking the promise of ... Not part of subscription

Concerns about "overdiagnosis" of breast cancer using AI are unfounded and miss the point

News Commentary | September 15, 2021

The use of AI in medical imaging for the diagnosis of breast cancer is seeing widespread adoption. Companies like Google and PathAI have shown impressive progress in detecting breast cancer, with high accuracy and low false positive rates. Concerns of "overdiagnosis" seem unfounded. While it is ... Not part of subscription